Progression of left atrial volume index in a population at risk for heart failure: A substudy of the STOP-HF (St Vincent's Screening to Prevent Heart Failure) trial

European Journal of Heart Failure

Volumn 14, Issue 9, 2012, Pages 957-964

  Collier, Patrick ^a,b   Watson, Chris J ^a   Waterhouse, Deidre F ^b   Dawkins, Ian R ^b   Patle, Anil K ^b   Horgan, Stephen ^a,b   Conlon, Carmel M ^a,b   O'Hanlon, Rory ^b   Baugh, John A ^a   Ledwidge, Mark T ^b   McDonald, Kenneth ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Biomarkers; Brain natriuretic peptide; Left atrial volume index; Pre heart failure; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM ENLARGEMENT; HEART FAILURE; HEART LEFT ATRIAL VOLUME INDEX; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEROLOGY;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART FAILURE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84865477701     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfs084     Document Type: Article

References (30)

1. Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett JC Jr, Jacobsen SJ, Rodeheffer RJ. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA 2011;306:856-863.
2. Marchese P, Bursi F, Delle Donne G, Malavasi V, Casali E, Barbieri A, Melandri F, Modena MG. Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion. Eur J Echocardiogr 2011;12: 214-221.
3. Ristow B, Ali S, Whooley MA, Schiller NB. Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the Heart and Soul Study). Am J Cardiol 2008;102:70-76.
4. Shuai XX, Chen YY, Lu YX, Su GH,Wang YH, Zhao HL, Han J. Diagnosis of heart failure with preserved ejection fraction: which parameters and diagnostic strategies are more valuable? Eur J Heart Fail 2011;13:737-745.
5. Suh IW, Song JM, Lee EY, Kang SH, Kim MJ, Kim JJ, Kang DH, Song JK. Left atrial volume measured by real-time 3-dimensional echocardiography predicts clinical outcomes in patients with severe left ventricular dysfunction and in sinus rhythm. J Am Soc Echocardiogr 2008;21:439-445.
6. Takemoto Y, Barnes ME, Seward JB, Lester SJ, Appleton CA, Gersh BJ, Bailey KR, Tsang TS. Usefulness of left atrial volume in predicting first congestive heart failure in patients . or 65 years of age with well-preserved left ventricular systolic function. Am J Cardiol 2005;96:832-836. (Pubitemid 41317661)
7. Tamura H, Watanabe T, Nishiyama S, Sasaki S, Arimoto T, Takahashi H, Shishido T, Miyashita T, Miyamoto T, Nitobe J, Hirono O, Kubota I. Increased left atrial volume index predicts a poor prognosis in patients with heart failure. J Card Fail 2011;17:210-216.
8. Wong RC, Yeo TC. Left atrial volume is an independent predictor of exercise capacity in patients with isolated left ventricular diastolic dysfunction. Int J Cardiol 2011;144:425-427.
9. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107-133.
10. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, Cha SS, Seward JB. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol 2006;47:1018-1023.
11. Pritchett AM, Jacobsen SJ, Mahoney DW, Rodeheffer RJ, Bailey KR, Redfield MM. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol 2003;41:1036-1043. (Pubitemid 36315550)
12. Leung DY, Chi C, Allman C, Boyd A, Ng AC, Kadappu KK, Leung M, Thomas L. Prognostic implications of left atrial volume index in patients in sinus rhythm. Am J Cardiol 2010;105:1635-1639.
13. Smit MD, Maass AH, Hillege HL, Wiesfeld AC, Van Veldhuisen DJ, Van Gelder IC. Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy. Eur J Heart Fail 2011;13:543-550.
14. Osranek M, Bursi F, Bailey KR, Grossardt BR, Brown RD Jr, Kopecky SL, Tsang TS, Seward JB. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J 2005;26: 2556-2561. (Pubitemid 41679360)
15. Jaubert MP, Armero S, Bonello L, Nicoud A, Sbragia P, Paganelli F, Arques S. Predictors of B-type natriuretic peptide and left atrial volume index in patients with preserved left ventricular systolic function: an echocardiographic-catheterization study. Arch Cardiovasc Dis 2010;103:3-9.
16. Weber KT, Janicki JS, Pick R, Abrahams C, Shroff SG, Bashey RI, Chen RM. Collagen in the hypertrophied, pressure-overloaded myocardium. Circulation 1987;75: I40-I47.
17. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-1446.
18. Biosca C, Ricos C, Lauzurica R, Galimany R, Hyltoft Petersen P. Reference change value concept combining two delta values to predict crises in renal posttransplantation. Clin Chem 2001;47:2146-2148. (Pubitemid 33108879)
19. Ricos C, Cava F, Garcia-Lario JV, Hernandez A, Iglesias N, Jimenez CV, Minchinela J, Perich C, Simon M, Domenech MV, Alvarez V. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004;64:175-184. (Pubitemid 38803101)
20. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112: e154-e235.
21. Alboni P, Razzolini R, Scarfo S, Paparella N, Fuca G, Pedini I, Chioin R. Hemodynamic effects of oral sotalol during both sinus rhythm and atrial fibrillation. J Am Coll Cardiol 1993;22:1373-1377. (Pubitemid 23316361)
22. Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A, Donnelly SC, McDonald K. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007;115:888-895. (Pubitemid 46294729)
23. Lee DS, Wang TJ, Vasan RS. Screening for ventricular remodeling. Curr Heart Fail Rep 2006;3:5-13. (Pubitemid 44623911)
24. O'Hanlon R, O'Shea P, Ledwidge M, O'Loughlin C, Lange S, Conlon C, Phelan D, Cunningham S, McDonald K. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. J Card Fail 2007;13:50-55. (Pubitemid 46330833)
25. Conlon CM, Dawkins I, O'Loughlin C, Gibson D, Kelleher CC, Ledwidge M, McDonald K. B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study. Clin Chem Lab Med 2011;49:719-728.
26. Luchner A, Burnett JC Jr, Jougasaki M, Hense HW, Riegger GA, Schunkert H. Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. J Am Coll Cardiol 1998;32:1839-1844. (Pubitemid 29010443)
27. Collier P, Watson CJ, Voon V, Phelan D, Jan A, Mak G, Martos R, Baugh JA, Ledwidge MT, McDonald KM. Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? Eur J Heart Fail 2011;13:1087-1095.
28. Donnelly R, Collinson DJ, Manning G. Hypertension, matrix metalloproteinases and target organ damage. J Hypertens 2003;21:1627-1630. (Pubitemid 37076343)
29. Vempati P, Karagiannis ED, Popel AS. A biochemical model of matrix metalloproteinase 9 activation and inhibition. J Biol Chem 2007;282:37585-37596.
30. Mak GJ, Ledwidge MT,Watson CJ, Phelan DM, Dawkins IR, Murphy NF, Patle AK, Baugh JA, McDonald KM. Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone. J Am Coll Cardiol 2009;54:1674-1682.